Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Colorcon
McKinsey
Johnson and Johnson
Dow

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Chlorpheniramine polistirex; codeine polistirex - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for chlorpheniramine polistirex; codeine polistirex and what is the scope of freedom to operate?

Chlorpheniramine polistirex; codeine polistirex is the generic ingredient in three branded drugs marketed by Lannett Co Inc, Fisons, and Aytu, and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorpheniramine polistirex; codeine polistirex has twenty-one patent family members in fourteen countries.

There are twenty-nine drug master file entries for chlorpheniramine polistirex; codeine polistirex. One supplier is listed for this compound.

Summary for chlorpheniramine polistirex; codeine polistirex
Recent Litigation for chlorpheniramine polistirex; codeine polistirex

Identify potential future generic entrants

District Court Litigation
Case NameDate
Tris Pharma Inc. v. Par Pharmaceutical Inc.2015-01-21
Tris Pharma Inc. v. Actavis Laboratories FL Inc.2014-10-15
RECKITT BENCKISER INC. v. TRIS PHARMA, INC.2009-06-26

See all chlorpheniramine polistirex; codeine polistirex litigation

Pharmacology for chlorpheniramine polistirex; codeine polistirex

US Patents and Regulatory Information for chlorpheniramine polistirex; codeine polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fisons PENNTUSS chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018928-001 Aug 14, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Aytu TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Lannett Co Inc CODEPREX chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 021369-001 Jun 21, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Aytu TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKesson
Mallinckrodt
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.